Digital mammography

Journal of the National Cancer Institute

Volumn 106, Issue 6, 2014, Pages

  Miller, Anthony B ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DIGITAL MAMMOGRAPHY; EARLY DIAGNOSIS; EDITORIAL; EGYPT; HEALTH CARE COST; HUMAN; MATHEMATICAL MODEL; PRIORITY JOURNAL; QUALITY OF LIFE; UNITED STATES; BREAST TUMOR; FEMALE; HEALTH CARE PLANNING; MAMMOGRAPHY; METHODOLOGY; MORTALITY; RADIOGRAPHY; SENSITIVITY AND SPECIFICITY; STANDARD;

BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MEDICALLY UNDERSERVED AREA; SENSITIVITY AND SPECIFICITY;

EID: 84903765316     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju125     Document Type: Editorial

References (13)

1. Pisano ED, Gatsonis C, Hendrick E, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353(17):1773-1783.
2. Stout NK, Lee SJ, Schechter CB, et al. Benefits, harms and costs for breast cancer screening following US implementation of digital mammography. J Natl Cancer Inst. 2014;106(6): dju092 doi:10.1093/jnci/dju092
3. Burton RC, Bell RJ, Thiagarajah G, Stevenson C. Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in Australian women since the national screening program began in 1991. Breast Cancer Res Treat. 2012;131 (3):949-955.
4. Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomized screening trial. BMJ. 2014;348:g366.
5. Hakama M, Auvinen A, Day NE, Miller AB. Sensitivity in cancer screening. J Med Screen. 2007;14(4):174-177.
6. Irwig L, Houssami N, Armstrong B, Glasziou P. Evaluating new screening tests for breast cancer. BMJ. 2006;332(7543):678-679.
7. Gross CP, Long JB, Ross JS, et al. The cost of breast cancer screening in the medicare population. JAMA Intern Med. 2013;173(3):220-226.
8. Henderson LM, Hubbard RA, Onega TL, et al. Assessing health care use and cost consequences of a new screening modality: the case of digital mammography. Med Care. 2012;50(12):1045-1052.
9. de Haes JC, de Koning HJ, van Oortmarssen GJ, van Agt HM, de Bruyn AE, van Der Maas PJ. The impact of a breast cancer screening programme on quality-adjusted life-years. Int J Cancer. 1991;49(4):538-544.
10. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367(21):1998-2005.
11. O'Donoghue C, Esserman L. Recognising the benefits and harms of breast cancer screening: an opportunity to target improvement. Br J Cancer. 2013;108(11):2200-2201.
12. Raftery J, Chorozoglou M. Possible net harms of breast cancer screening: updated modelling of Forrest report. BMJ. 2011 December 8;343:d7627.
13. Fryback DG, Stout NK, Rosenberg MA, Trentham-Dietz A, Kuruchittham V, Remington PL. The Wisconsin breast cancer epidemiology simulation model. J Natl Cancer Inst Monogr. 2006;36:37-47.